A detailed history of Hb Wealth Management, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Hb Wealth Management, LLC holds 199,614 shares of PFE stock, worth $5.37 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
199,614
Previous 189,003 5.61%
Holding current value
$5.37 Million
Previous $5.29 Million 9.23%
% of portfolio
0.06%
Previous 0.06%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$27.7 - $31.39 $293,924 - $333,079
10,611 Added 5.61%
199,614 $5.78 Million
Q2 2024

Jul 26, 2024

SELL
$25.26 - $29.6 $5,986 - $7,015
-237 Reduced 0.13%
189,003 $5.29 Million
Q1 2024

Apr 30, 2024

BUY
$25.89 - $29.73 $660,013 - $757,906
25,493 Added 15.57%
189,240 $5.25 Million
Q4 2023

Jan 16, 2024

SELL
$26.13 - $33.94 $1.08 Million - $1.41 Million
-41,434 Reduced 20.19%
163,747 $4.71 Million
Q3 2023

Oct 13, 2023

SELL
$32.09 - $37.51 $55,323 - $64,667
-1,724 Reduced 0.83%
205,181 $6.81 Million
Q2 2023

Jul 13, 2023

BUY
$36.12 - $41.79 $246,916 - $285,676
6,836 Added 3.42%
206,905 $7.59 Million
Q1 2023

Apr 13, 2023

SELL
$39.39 - $51.28 $5.57 Million - $7.25 Million
-141,341 Reduced 41.4%
200,069 $8.16 Million
Q4 2022

Jan 20, 2023

BUY
$41.75 - $54.5 $12,900 - $16,840
309 Added 0.09%
341,410 $0
Q3 2022

Oct 19, 2022

BUY
$43.76 - $53.42 $3.18 Million - $3.88 Million
72,680 Added 27.08%
341,101 $14.9 Million
Q2 2022

Jul 15, 2022

BUY
$46.53 - $55.17 $788,962 - $935,462
16,956 Added 6.74%
268,421 $14.1 Million
Q1 2022

May 16, 2022

BUY
$45.75 - $56.69 $1.41 Million - $1.74 Million
30,768 Added 13.94%
251,465 $13 Million
Q4 2021

Feb 15, 2022

BUY
$41.32 - $61.25 $9.12 Million - $13.5 Million
220,697 New
220,697 $13 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $151B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Hb Wealth Management, LLC Portfolio

Follow Hb Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hb Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hb Wealth Management, LLC with notifications on news.